Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23085346 | 0.91 | TSHR (0.41) | TSHRADRB2 | |
| SCHEMBL23069596 | 0.89 | TSHR (0.42) | TSHRADRB2 | |
| SCHEMBL23085389 | 0.88 | TSHR (0.41) | TSHRADRB2 | |
| SCHEMBL26839821 | 0.86 | TSHR (0.41) | TSHR | |
| SCHEMBL23085280 | 0.84 | TSHR (0.39) | TSHR | |
| SCHEMBL23085276 | 0.84 | TSHR (0.39) | TSHR | |
| SCHEMBL22783612 | 0.84 | TSHR (0.36) | TSHR | |
| SCHEMBL23085368 | 0.83 | TSHR (0.38) | TSHR | |
| SCHEMBL23085327 | 0.82 | TSHR (0.40) | TSHR | |
| SCHEMBL23085475 | 0.82 | TSHR (0.40) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230079107-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | CIDARA THERAPEUTICS, INC. | 2023-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230079107-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | FCGR3B, FCGR1A, FCGR2A | TSHR 2189/4885ADRB2 4369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.